Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infected physicians and invasive procedures: safe practice management.

Angelique M Reitsma1, Michael L Closen, Marshall Cunningham

  • 1The Center for Biomedical Ethics, University of Virginia Health Science Center, Charlottesville, VA 22908-0758, USA. ar6j@virginia.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|May 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Pfcrt</i> copy number amplification detected in a <i>Plasmodium falciparum</i> outbreak.

bioRxiv : the preprint server for biology·2026
Same author

Cardiac Intensive Care Unit Availability in Rural America: Insights From a Statewide Analysis in Missouri, USA.

Journal of cardiac failure - intersections·2026
Same author

How "America First" Abandoned Global Health: The Case for an African Model.

The American journal of bioethics : AJOB·2026
Same author

Fluid Management of Acute Heart Failure With the Reprieve System: The Randomized Controlled FASTR Trial.

JACC. Heart failure·2026
Same author

RACGAP1 as a Circulating Biomarker of Atrial Fibrillation in Heart Failure: A Dual-Cohort Proteomic Study.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Common Genetic Variants of The Cardiac Sodium Channel Alter Patient Response to Class 1b Antiarrhythmics.

bioRxiv : the preprint server for biology·2026
Same journal

The balance between a new Antibiotic and Non-antibiotic Alternatives for the treatment and prevention of uncomplicated Urinary Tract Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Physicians infected with hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) require clear policy guidelines for performing invasive procedures. This study proposes recommendations for managing infected physicians and outlines conditions for practice.

Area of Science:

  • Medical Ethics
  • Public Health Policy
  • Infectious Diseases

Background:

  • Lack of current public policy guidance for healthcare professionals with HBV, HCV, and HIV performing invasive procedures.
  • Need for evidence-based recommendations to ensure patient safety and physician rights.
  • Ethical considerations surrounding serostatus disclosure and professional practice.

Purpose of the Study:

  • To develop policy recommendations for physicians infected with HBV, HCV, and/or HIV.
  • To establish guidelines for managing infected physicians engaged in invasive procedures.
  • To define conditions under which infected physicians can continue practice.

Main Methods:

  • Convening a multidisciplinary expert committee including medicine, law, and bioethics specialists.

Related Experiment Videos

  • Conducting an extensive literature review across infectious diseases, medicine, surgery, epidemiology, law, and bioethics.
  • Developing a policy proposal with a list of exposure-prone procedures and a decision chart.

    • Main Results:

    • Identification of key data from literature review to inform policy.
    • Formulation of specific recommendations for managing physicians with HIV, HBV, and/or HCV.
    • Creation of a decision-making framework for practice continuation based on procedure risk and serostatus.

    Conclusions:

    • The proposed policy provides a framework for managing infected physicians.
    • Recommendations aim to balance patient safety with the professional rights of infected physicians.
    • The policy addresses the need for clear guidelines on practice limitations and disclosure for physicians with HBV, HCV, and HIV.